Résultats de la recherche
10
Tout
Rechercher les filtres
Organisation
Celularity Inc.
Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products
25 févr. 2025 08h00 HE
|
Celularity Inc.
FLORHAM PARK, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that on December...
Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company
24 févr. 2025 08h00 HE
|
Celularity Inc.
FLORHAM PARK, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that it has...
MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs
27 janv. 2025 08h00 HE
|
Celularity Inc.
FLORHAM PARK, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Celularity issues the following announcement on behalf of the members of the MASS Coalition: MASS Coalition Welcomes Trump Order Freezing Skin...
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
10 déc. 2024 08h00 HE
|
Celularity Inc.
FLORHAM PARK, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that it has...
Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023
06 déc. 2024 08h00 HE
|
Celularity Inc.
Celularity filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024, and is now current with its quarterly report filings Reported Total Net Revenue for the Three Months and...
Celularity Inc. Announces Receipt of Nasdaq Notification
27 nov. 2024 17h00 HE
|
Celularity Inc.
FLORHAM PARK, N.J., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative medicine company developing placental-derived allogeneic cell...
Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific
20 nov. 2024 08h30 HE
|
Celularity Inc.
Celularity is collaborating with its strategic partner, Genting Berhad, to bring Celularity placenta-derived allogeneic stem cell therapeutics to the Asia Pacific regionGenting Berhad announced...
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
18 nov. 2024 08h30 HE
|
Celularity Inc.
FLORHAM PARK, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that the Nasdaq Listing...
Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
07 nov. 2024 08h00 HE
|
Celularity Inc.
Celularity Raises Full Year 2024 Expected Net Sales Guidance to $54 Million to $60 Million, Compared to Previous Guidance of $50 Million to $56 MillionOctober Expected Net Sales of $8.3 Million to...
Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel
23 oct. 2024 08h30 HE
|
Celularity Inc.
FLORHAM PARK, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it has requested a hearing...